Vaishali Pharma Limited
Incorporated in 1989, Vaishali Pharma Ltddoes marketing of pharmaceutical products including active pharmaceutical ingredients
What Vaishali files
- Others50
- Board Meeting14
- Updates6
- Important3
- Results3
- Dividend/Bonus1
Vaishali Pharma received NSE approval to list 45.38 lakh new equity shares issued on a preferential basis. This enables trading of these shares once credited to beneficiary accounts, enhancing liquidity.
Vaishali Pharma to hold its 19th AGM. A record date for e-voting eligibility and a book closure period for share transfers have been fixed. Important for shareholder participation.
Vaishali Pharma allotted 45,37,865 equity shares at Rs. 20/share (Rs. 9.08 Cr total) to Kesar Pharma. This share swap enables acquiring a 26.95% stake in KPL, boosting Vaishali's paid-up equity capital. This is a key business development.
Company adjusted a preferential share issuance with Kesar Pharma. It will receive Rs 0.02 Cr cash from KPL to align the transaction value following a valuation difference.
The Promoter and Promoter Group confirmed no shares were encumbered (pledged) during the last financial year. This indicates stable promoter holdings, a positive sign for investors.